News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos resigned on Tuesday as co-leader of a U.S. CDC working ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
The FDA is proposing to limit annual COVID-19 ... by Novavax Inc. Vaccine manufacturers have said that because COVID vaccines change annually to target specific strains of the virus, the ...
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to ...
Dr. Marty Makary, the Johns Hopkins surgeon and professor who Trump tapped to lead the FDA, clarified the recently changed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback